小梁骨评分与终末期肾病患者的骨密度、骨转换标志物及现患骨折相关
该研究纳入147例终末期肾病(ESKD)患者,在移植前4周内完成实验室检查、双能X射线吸收测定(DXA)、侧位脊柱X线及结构化病史采集,评估小梁骨评分(TBS)与人口学资料、现患骨折、骨密度及实验室指标的关联。结果显示,较低的TBS与1型糖尿病、更高的骨转换标志物及现患非椎体骨折相关。
要点
- 平均TBS为1.345±0.125,胰肾联合移植(SPK)患者低于单纯肾移植患者(1.292 vs 1.364,p=0.001)。
- TBS与脊柱和全髋骨密度、体重指数相关,与甲状旁腺激素、碱性磷酸酶及1型前胶原N端前肽呈负相关。
- 多变量logistic回归显示,较低的TBS与既往非椎体骨折显著相关(p=0.026)。
核心结论
- 较低的TBS提示微结构损伤增加,与1型糖尿病、更高的骨转换标志物及现患骨折相关。
- 这些数据支持需要前瞻性研究来评估纳入TBS是否能改善ESKD患者的骨折预测。
研究设计与样本
- 本研究为在147例接受肾移植及胰肾联合移植(SPK)的ESKD患者中开展的移植前评估研究。
- 患者在移植后4周内接受移植前实验室检查、DXA、侧位脊柱X线及结构化病史采集。
- 评估TBS与人口学资料、现患骨折、骨密度及实验室变量的关联。
主要发现
- 147例患者中60%为男性,平均年龄48±13岁,36%患糖尿病,54例有骨折:21例仅为现患椎体骨折,22例仅为非椎体骨折,11例两者兼有。
- 平均TBS为1.345±0.125,SPK患者低于单纯肾移植患者(1.292 vs 1.364,p=0.001)。
- TBS与脊柱和全髋骨密度、体重指数相关,与甲状旁腺激素、碱性磷酸酶及1型前胶原N端前肽呈负相关。
- 多变量logistic回归显示,较低的TBS与既往非椎体骨折显著相关(p=0.026)。
关键数值与推荐
- 较低的TBS与既往非椎体骨折相关(多变量logistic回归p=0.026)。
- SPK患者平均TBS低于单纯肾移植患者(1.292 vs 1.364,p=0.001)。
- TBS与脊柱和全髋骨密度、体重指数相关,与甲状旁腺激素、碱性磷酸酶及1型前胶原N端前肽呈负相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Fracture risk increases in end-stage kidney disease (ESKD), but bone mineral density (BMD) measurement is less predictive of risk than in the general population. In this study of patients with ESKD, a lower trabecular bone score (TBS), indicative of microarchitectural deterioration, was associated with higher bone turnover markers and prevalent non-vertebral fracture. INTRODUCTION: Declining renal function carries increased fracture risks, but BMD is less predictive of fracture for dialysis patients than the general population. The TBS, obtained from lumbar spine dual-energy X-ray absorptiometry (DXA) images, provides information on microarchitectural integrity not captured by BMD. The aim of this study was to assess associations of the TBS to clinical, DXA, radiological, and laboratory measures in patients with ESKD undergoing kidney and simultaneous pancreas kidney (SPK) transplantation. METHODS: A total of 147 patients with ESKD underwent pre-transplant laboratory testing, DXA, lateral spine X-ray, and structured history within 4 weeks of transplantation. Associations of the TBS to demographic data, prevalent fracture, BMD, and laboratory variables were assessed. RESULTS: Of 147 patients (60% male, mean age 48 ± 13 years), 36% had diabetes mellitus (DM) and 54 patients had fractures: 21 prevalent vertebral fractures only, 22 non-vertebral fractures only, and 11 had both. The mean TBS (1.345 ± 0.125) was lower in patients undergoing SPK than kidney-only transplants (1.292 vs. 1.364, p = 0.001). The TBS correlated to spine and total hip BMD, body mass index and inversely to parathyroid hormone, alkaline phosphatase and procollagen 1 N-propeptide. By multivariable logistic regression, lower TBS was significantly associated to prior non-vertebral fracture (p = 0.026). CONCLUSIONS: A lower TBS, suggestive of increased microarchitectural damage, was associated with type 1 DM, markers of higher bone turnover, and prevalent fracture. These data support the need for prospective studies to evaluate whether TBS inclusion improves fracture prediction in patients with ESKD.
引用
- Aleksova J, Kurniawan S, Elder GJ, et al. The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease. Osteoporos Int. 2018. PMID: 29556678. doi:10.1007/s00198-018-4468-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。